Free Newsletter
| Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today! |
Boston Scientific preps for big layoffs
Welcome to the wake, Boston Scientific. The device maker is poised to join its healthcare colleagues in laying off thousands of workers. Analysts that follow the company predict it will cut up to 12 percent of its global workforce, or up to 3,400 people.
Boston Scientific already cut some 500 to 600 jobs this year. Company officials said this summer that they'd announce more layoffs by year's end; that word is expected soon, perhaps this week. The company has been faltering since it bought Guidant two years ago, loaded as it is with debt and beset by falling sales of its drug-coated stents.
- read the article from the Boston Globe
Related Articles:
Boston Scientific deals with debt. Report
Tough times for stent market. Report
Boston Scientific implant gets EU nod. Report
Read more on: Boston Scientific
Be the first to comment
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
